CoverageForm 410-K10-Q8-K13D13G13F

Guse Kyle

CIK 0001566618
CFO, Gen Counsel and SecretaryDirector

Filings

4

Latest May 18, 2026

Issuers covered

2

Showing

4 of 4

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Guse Kyle. Track record appears once open-market purchases or sales reach the +30 day horizon.

Issuers

Companies where Guse Kyle has filed

TickerIssuerFilingsLast filed
ATOSAtossa Therapeutics, Inc.2Mar 6, 2023
PSTVPlus Therapeutics, Inc.2May 18, 2026

All filings

4 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue